ARCKU
Closed
Arbor Rapha Capital Bioholdings Corp I Unit
12.
0 (0.00%)
Last Update: 10 Mar 2023 17:30:00
Yesterday: 12.
Day's Range: 12. - 12.
Send
sign up or login to leave a comment!
When Written:
12
Arbor Rapha Capital Bioholdings Corp I Unit is a special purpose acquisition company (SPAC) that was formed to acquire or merge with one or more businesses in the biotechnology and healthcare industries. The company's focus is on identifying and acquiring companies that have innovative technologies and products with significant potential for growth and profitability.
The SPAC is sponsored by Arbor Rapha Capital Partners, a private equity firm that specializes in healthcare investments. The company raised $200 million in its initial public offering (IPO) in February 2021.
The units of Arbor Rapha Capital Bioholdings Corp I began trading on the NASDAQ under the ticker symbol "ABEBU" on February 5, 2021. Each unit consists of one share of common stock and one-third of a redeemable warrant, which can be exercised to purchase one share of common stock at a price of $11.50 per share.
The company's management team includes experienced executives and investors with a track record of success in the healthcare industry. The team is led by CEO and Chairman Richard J. Gumer, who has more than 30 years of experience in healthcare and investment banking.
Overall, Arbor Rapha Capital Bioholdings Corp I Unit is a SPAC that aims to acquire or merge with promising biotechnology and healthcare companies with the potential for significant growth and profitability.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
The SPAC is sponsored by Arbor Rapha Capital Partners, a private equity firm that specializes in healthcare investments. The company raised $200 million in its initial public offering (IPO) in February 2021.
The units of Arbor Rapha Capital Bioholdings Corp I began trading on the NASDAQ under the ticker symbol "ABEBU" on February 5, 2021. Each unit consists of one share of common stock and one-third of a redeemable warrant, which can be exercised to purchase one share of common stock at a price of $11.50 per share.
The company's management team includes experienced executives and investors with a track record of success in the healthcare industry. The team is led by CEO and Chairman Richard J. Gumer, who has more than 30 years of experience in healthcare and investment banking.
Overall, Arbor Rapha Capital Bioholdings Corp I Unit is a SPAC that aims to acquire or merge with promising biotechnology and healthcare companies with the potential for significant growth and profitability.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!